South and Central America Coil Assisted Flow Diverters Market is expected to reach US$ 22.36 million by 2028


PRESS RELEASE BY The Insight Partners 03 Aug 2021

Share this press on


The wide-neck bifurcation aneurysms segment by application is estimated to lead the market growth during the forecast period.

According to The Insight Partners market research study of “South and Central America Coil Assisted Flow Diverters Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Application, End User and Country.” The South and Central America coil assisted flow diverters market is expected to reach US$ 22.36 million in 2028 from US$ 14.22 million in 2021; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028. The report highlights trends prevailing in the South and Central America coil assisted flow diverters market and the factors driving market along with those that act as hindrances. Key factors that are driving growth of the market are rising incidence of intracranial aneurysms and growing incidence of hypertension, smoking, alcoholism, and obesity fuel the growth of the market. However, high cost of neurosurgical devices is expected to restrict the market growth during the forecast period.

Coil assisted flow diverters are stent-like devices that are used to for the embolization of intracranial aneurysms. Thus, increasing incidence of intracranial aneurysms is propelling the demand for coil assisted flow diverters. According to NCBI, in 2019, an epidemiological analysis of Brazilian patients diagnosed with cerebral aneurysms showed 2251 aneurysms in 1404 patients with a 3:4 female/male ratio. A higher incidence of intracranial aneurysms was found among the females as compared to male. Thus, increasing prevalence of intracranial aneurysms is creating high demand for coil assisted flow diverters. Also, hypertension, smoking, alcoholism, and obesity are associated with the development of brain aneurysms. Thus, increasing prevalence of these diseases is likely to fuel the demand for coil assisted flow diverters. In addition to this, the growing geriatric population, the rise in associated neurological disorders and technological advancements in coil assisted flow diverters across Latin America are likely to create growth opportunities for the market.

With the outbreak of second wave COVID-19, there has been an increasing number of cases in the South American countries. In this scenario, Brazil has observed enormous difficulties in management of chronic neurological disorders, from headache to neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments due to decompensation of their neurological disease. During the pandemic, stroke patients as well as other neurological conditions have been arriving late at the hospital, outside the therapeutic window for acute intervention. In addition, the country also faced difficulties in obtaining beds in the intensive care unit for management of the diseases during the acute phase. These factors are likely to have negative impact on the market growth.

The South and Central America coil assisted flow diverters market, by application, is segmented into wide-neck bifurcation aneurysms, and narrow bifurcation aneurysms. Based on end user, the South and Central America coil assisted flow diverters market is segmented into hospitals, clinics, and ambulatory surgical centers. Geographically, the South and Central America coil assisted flow diverters market cab be sub-segmented into Brazil, Argentina and Rest of South and Central America.

Balt USA LLC, Stryker Corporation, Penumbra, Inc, Medtronic, MicroPort Scientific Corporation, Acandis GmbH, MicroVention Inc, and Johnson and Johnson Services, Inc., are among the leading companies operating in the South and Central America coil assisted flow diverters market.

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com 

Download Free PDF Brochure